The HLA-G gene repression can be reversed by demethylating agents used in some cancer therapies such as 5-aza-2′-deoxycytidine [71, 72] and inhibitors of histone deacetylases [72] and may directly induce HLA-G cell surface expression. Here, HLA-G is linked to cancer.